Scunthorpe General Hospital is the main hospital for North Lincolnshire. It is situated on Church Lane in the west of Scunthorpe, off Kingsway, and north of the railway. A & E is at the far north of the site, accessed via Highfield Avenue, off Doncaster Road. As well as North Lincolnshire, it also serves Gainsborough.

There are 408 beds in Scunthorpe General Hospital.

During the past decade, Scunthorpe General Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Scunthorpe General Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 3 trials, followed by "Lymphoma Trials Office" with 3 trials sponsored, "University of Leeds" with 3 trials sponsored, "Cancer Research UK" with 2 trials sponsored and "University College, London" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scunthorpe General Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Scunthorpe General Hospital" are "Breast Cancer" (5 trials), "Lymphoma" (4 trials), "Prostate Cancer" (4 trials), "Metastatic Cancer" (3 trials) and "Hypercalcemia of Malignancy" (2 trials). Many other conditions were trialed in "Scunthorpe General Hospital" in a lesser frequency.

Most popular intervention types in "Scunthorpe General Hospital" are "Drug" (27 trials), "Procedure" (7 trials), "Biological" (4 trials), "Other" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "adjuvant therapy" (5 trials), "doxorubicin hydrochloride" (4 trials), "vincristine sulfate" (4 trials) and "CHOP regimen" (3 trials). Other intervention names were less common.

The vast majority of trials in "Scunthorpe General Hospital" are 24 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Scunthorpe General Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Scunthorpe General Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Scunthorpe General Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".